Neuphoria Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 875.33 K | $3.83 M | 0.00% | 16.18% |
| ADVISORSHARES INVESTMENTS LLC | 08/11/2026 | 252.91 K | $1.11 M | 62.78% | 4.67% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 173.49 K | $758.14 K | 76.10% | 3.21% |
| SHAY CAPITAL LLC | 08/14/2026 | 155.82 K | $680.94 K | 3.19% | 2.88% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 142.23 K | $621.54 K | 0.03% | 2.63% |
| CITADEL ADVISORS LLC | 09/02/2026 | 72.56 K | $317.08 K | 275.35% | 1.34% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 49.52 K | $216.38 K | -4.79% | 0.92% |
| IKARIAN CAPITAL, LLC | 08/14/2026 | 47.44 K | $207.33 K | 0.00% | 0.88% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 33.81 K | $147.73 K | 0.65% | 0.62% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 30.00 K | $131.10 K | 0.00% | 0.55% |
| FNY INVESTMENT ADVISERS, LLC | 07/08/2026 | 26.50 K | $115.00 K | 0.00% | 0.49% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 25.50 K | $111.44 K | 100.00% | 0.47% |
| XTX TOPCO LTD | 08/14/2026 | 23.09 K | $100.90 K | 100.00% | 0.43% |
| HRT FINANCIAL LP | 08/14/2026 | 22.87 K | $99.00 K | 100.00% | 0.42% |
| JANE STREET GROUP, LLC | 08/14/2026 | 14.90 K | $65.13 K | 100.00% | 0.28% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 14.00 K | $61.18 K | 0.00% | 0.26% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/29/2026 | 11.22 K | $49.04 K | 0.00% | 0.21% |
| NORTHERN TRUST CORP | 08/13/2026 | 10.61 K | $46.37 K | 100.00% | 0.20% |
| MERCK & CO., INC. | 08/07/2026 | 10.03 K | $43.82 K | 0.00% | 0.19% |
| UBS GROUP AG | 08/13/2026 | 2.12 K | $9.25 K | -8.59% | 0.04% |
| MORGAN STANLEY | 08/13/2026 | 58 | $254 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 3 | $13 | 100.00% | 0.00% |
| RHUMBLINE ADVISERS | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neuphoria Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Neuphoria Therapeutics Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 875,328
AdvisorShares Investments LLC: 252,909
VANGUARD CAPITAL MANAGEMENT LLC: 173,488
Shay Capital LLC: 155,822
BALYASNY ASSET MANAGEMENT L.P.: 142,228
CITADEL ADVISORS LLC: 72,559
36.85% of Neuphoria Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.01 M shares in the last 24 months. This purchase volume represents approximately $9.15 M in transactions.